25 Results

People

  1. Bodei
    Bodei
  2. Pinker-Domenig
    Pinker-Domenig
  3. Hellmann
    Hellmann
  4. Callahan
    Callahan
  5. Castel
    Castel
  6. Chaft
    Chaft
  7. Devlin
    Devlin
  8. Janjigian
    Janjigian
  9. Landau
    Landau
  10. Li
    Li

Groups

  1. Department of Medicine (12)
  2. Sloan Kettering Institute Postdocs (11)
  3. Radiology, Department of (10)
  4. Solid Tumor Oncology Division (8)
  5. Molecular Imaging and Therapy Service (7)
  6. Center for Hematologic Malignancies (4)
  7. Hematologic Malignancies, Division of (4)
  8. Thoracic Oncology (4)
  9. Breast Imaging Service (3)
  10. Executive Committee, Center for Hematologic Malignancies (2)
  1. "2017"
  2. "S. Karger AG"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (6)
Groups
  1. Department of Medicine (12)
  2. Sloan Kettering Institute Postdocs (11)
  3. Radiology, Department of (10)
  4. Solid Tumor Oncology Division (8)
  5. Molecular Imaging and Therapy Service (7)
  6. Center for Hematologic Malignancies (4)

More Groups

People
  1. Lisa Bodei (7)
  2. Katja Pinker-Domenig (3)
  3. Matthew Hellmann (2)
  4. Anas Younes (1)
  5. Bob Li (1)
  6. Diane Reidy (1)

More People

Years
  1. 2017 (25)
Publications
  1. Neuroendocrinology (10)
  2. Oncology Research and Treatment (10)
  3. Breast Care (3)
  4. Human Heredity (1)
  5. Journal of Vascular Research (1)
Publishers
  1. S. Karger AG (25)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A hybrid clinical molecular nomogram accurately predicts survival in PRRT treated GEP-NETs
    Meeting Abstract

    Kidd, M.; Bodei, L.; Severi, S.; Drozdov, I.; Nicolini, S.; Paganelli, G.; Modlin, I. M.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Survival analysis after i.a. 90Y-DOTATATE PRRT, in patients with non-resectable, advanced, progressive, liver-dominant neuroendocrine neoplasms
    Meeting Abstract

    Nowicki, M. L.; Kolasińska-Ćwikła, A.; Lewczuk, A.; Sankowski, A.; Bodei, L.; Buscombe, J. R.; Kidd, M.; Modlin, I.; Ćwikła, J.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in combination with peptide receptor radionuclide therapy (PRRT) in progressive digestive and lung neuroendocrine tumours (NETs): Design of the PRELUDE study
    Meeting Abstract

    Prasad, V.; Thanh, X. M. T.; Houchard, A.; Bodei, L.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Resection of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas: A Nordic multicenter study
    Meeting Abstract

    Galleberg, R. B.; Knigge, U.; Janson, E. T.; Vestermark, L. W.; Haugvik, S. P.; Ladekarl, M.; Langer, S. W.; Grønbæk, H.; Österlund, P.; Hjortland, G.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Measurement in blood of a circulating NET mRNA gene to predict surgical efficacy
    Meeting Abstract

    Modlin, I. M.; Frilling, A.; Salem, R.; Cichocki, A.; Ćwikła, J.; Bodei, L.; Drozdov, I.; Kidd, M.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Circulating neuroendocrine transcripts and gene cluster analysis predict the efficacy of PRRT
    Meeting Abstract

    Bodei, L.; Kidd, M.; Singh, A.; Severi, S.; Drozdov, I.; Nicolini, S.; Baum, R.; Paganelli, G.; Kwekkeboom, D.; Krenning, E.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in lung neuroendocrine tumours (NETs): The randomized, double-blind, placebo (PBO)-controlled, international phase 3 SPINET study
    Meeting Abstract

    Reidy-Lagunes, D.; Kulke, M. H.; Wolin, E. M.; Singh, S.; Ferone, D.; Hörsch, D.; Mirakhur, B.; Hoffmanns, P.; Houchard, A.; Caplin, M.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Clinical nomogram development and predictive utility for appendiceal and colorectal NETs
    Meeting Abstract

    Kolasińska-Ćwikła, A.; Ćwikła, J.; Kidd, M.; Bodei, L.; Lewczuk, A.; Drozdov, I.; Modlin, I.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Anti-CTLA-4 checkpoint inhibitormediated anticancer immunity relies on tumor-intrinsic RIG-I signaling
    Meeting Abstract

    Heidegger, S.; Wintges, A.; Bek, S.; Schmickl, M.; Steiger, K.; Koenig, P. A.; Ruland, J.; van den Brink, M. R. M.; Peschel, C.; Haas, T.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Nivolumab ± ipilimumab in patients (pts) with advanced (adv) / metastatic chemotherapy-refractory (CTx-R) gastric (G), esophageal (E), or gastroesophageal junction (GEJ) cancer: CheckMate 032 study
    Meeting Abstract

    Jaeger, D.; Janjigian, Y. Y.; Ott, P. A.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Peltola, K.; Evans, J.; de Braud, F.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save